Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0WPASO
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
KTN-0125
|
|||||
| Synonyms |
CDX-0125-TEI; KTN0125; KTN 0125
Click to Show/Hide
|
|||||
| Organization |
Kolltan Pharmaceuticals, Inc.; Celldex Therapeutics, Inc.
|
|||||
| Drug Status |
Investigative
|
|||||
| Indication |
In total 1 Indication(s)
Neuroblastoma [ICD11:2A00]
Investigative
|
|||||
| Antibody Name |
Undisclosed
|
|||||
| Antigen Name |
ALK tyrosine kinase receptor (ALK)
|
Antigen Info | ||||
| Payload Name |
Undisclosed
|
|||||
| Linker Name |
Undisclosed
|
|||||
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.